Literature DB >> 24812340

Inferring the paths of somatic evolution in cancer.

Navodit Misra1, Ewa Szczurek2, Martin Vingron1.   

Abstract

MOTIVATION: Cancer cell genomes acquire several genetic alterations during somatic evolution from a normal cell type. The relative order in which these mutations accumulate and contribute to cell fitness is affected by epistatic interactions. Inferring their evolutionary history is challenging because of the large number of mutations acquired by cancer cells as well as the presence of unknown epistatic interactions.
RESULTS: We developed Bayesian Mutation Landscape (BML), a probabilistic approach for reconstructing ancestral genotypes from tumor samples for much larger sets of genes than previously feasible. BML infers the likely sequence of mutation accumulation for any set of genes that is recurrently mutated in tumor samples. When applied to tumor samples from colorectal, glioblastoma, lung and ovarian cancer patients, BML identifies the diverse evolutionary scenarios involved in tumor initiation and progression in greater detail, but broadly in agreement with prior results.
AVAILABILITY AND IMPLEMENTATION: Source code and all datasets are freely available at bml.molgen.mpg.de. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Year:  2014        PMID: 24812340     DOI: 10.1093/bioinformatics/btu319

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  13 in total

1.  Algorithmic methods to infer the evolutionary trajectories in cancer progression.

Authors:  Giulio Caravagna; Alex Graudenzi; Daniele Ramazzotti; Rebeca Sanz-Pamplona; Luca De Sano; Giancarlo Mauri; Victor Moreno; Marco Antoniotti; Bud Mishra
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-28       Impact factor: 11.205

Review 2.  The evolution of tumour phylogenetics: principles and practice.

Authors:  Russell Schwartz; Alejandro A Schäffer
Journal:  Nat Rev Genet       Date:  2017-02-13       Impact factor: 53.242

3.  Cooperative genomic alteration network reveals molecular classification across 12 major cancer types.

Authors:  Hongyi Zhang; Yulan Deng; Yong Zhang; Yanyan Ping; Hongying Zhao; Lin Pang; Xinxin Zhang; Li Wang; Chaohan Xu; Yun Xiao; Xia Li
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

4.  Whole-exome sequencing predicted cancer epitope trees of 23 early cervical cancers in Chinese women.

Authors:  Xia Li; Hailiang Huang; Yanfang Guan; Yuhua Gong; Cheng-Yi He; Xin Yi; Ming Qi; Zhi-Ying Chen
Journal:  Cancer Med       Date:  2016-12-20       Impact factor: 4.452

5.  Reconstruction of kidney renal clear cell carcinoma evolution across pathological stages.

Authors:  Shichao Pang; Yidi Sun; Leilei Wu; Liguang Yang; Yi-Lei Zhao; Zhen Wang; Yixue Li
Journal:  Sci Rep       Date:  2018-02-20       Impact factor: 4.379

6.  Analysis of mutation, selection, and epistasis: an informed approach to cancer clinical trials.

Authors:  Jon F Wilkins; Vincent L Cannataro; Brian Shuch; Jeffrey P Townsend
Journal:  Oncotarget       Date:  2018-04-27

7.  Collaborative intra-tumor heterogeneity detection.

Authors:  Sahand Khakabimamaghani; Salem Malikic; Jeffrey Tang; Dujian Ding; Ryan Morin; Leonid Chindelevitch; Martin Ester
Journal:  Bioinformatics       Date:  2019-07-15       Impact factor: 6.937

8.  Cancer progression models and fitness landscapes: a many-to-many relationship.

Authors:  Ramon Diaz-Uriarte
Journal:  Bioinformatics       Date:  2018-03-01       Impact factor: 6.937

9.  Dynamic changes of driver genes' mutations across clinical stages in nine cancer types.

Authors:  Xia Li
Journal:  Cancer Med       Date:  2016-03-19       Impact factor: 4.452

10.  Mutational interactions define novel cancer subgroups.

Authors:  Jack Kuipers; Thomas Thurnherr; Giusi Moffa; Polina Suter; Jonas Behr; Ryan Goosen; Gerhard Christofori; Niko Beerenwinkel
Journal:  Nat Commun       Date:  2018-10-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.